All non-muscle invasive bladder cancer articles
-
NewsFerring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
Ferring Pharmaceuticals launches state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin® (nadofaragene firadenovec-vncg), an adenovirus vector-based gene therapy.
